Predict your next investment

Private Equity
olympuspartners.com

See what CB Insights has to offer

Investments

30

Portfolio Exits

24

Funds

8

Partners & Customers

2

Service Providers

1

About Olympus Partners

Olympus Partners (Olympus) is a private equity firm that provides equity capital to privately held, middle-market business services, logistics, healthcare, financial services, consumer products and information technology companies. Olympus manages over $3.1 billion on behalf of corporate pension plans, public retirement systems, university endowment funds, and the executives of Olympus' portfolio companies.

Olympus Partners Headquarter Location

Metro Center, 4th Floor One Station Place

Stamford, Connecticut, 06902,

United States

203-353-5900

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Olympus Partners News

Olympus Partners acquires gyms franchisee

May 3, 2022

Olympus Partners, the US-based private equity firm specialising in middle-market buyouts, has acquires Excel Fitness Holdings, a Planet Fitness franchisee which operates over 80 locations. The post Olympus Partners acquires gyms franchisee appeared first on The MBS Group.

Olympus Partners Investments

30 Investments

Olympus Partners has made 30 investments. Their latest investment was in Tank Holding as part of their Recap on April 4, 2022.

CBI Logo

Olympus Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/11/2022

Recap

Tank Holding

$1,685M

No

1

5/22/2014

Private Equity

Pregis North America

Yes

1

8/11/2011

Series D

Siva Power

$23.47M

No

2

6/17/2010

Series C

Subscribe to see more

$99M

Subscribe to see more

0

4/24/2009

Growth Equity

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/11/2022

5/22/2014

8/11/2011

6/17/2010

4/24/2009

Round

Recap

Private Equity

Series D

Series C

Growth Equity

Company

Tank Holding

Pregis North America

Siva Power

Subscribe to see more

Subscribe to see more

Amount

$1,685M

$23.47M

$99M

$99M

New?

No

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

2

0

10

Olympus Partners Portfolio Exits

24 Portfolio Exits

Olympus Partners has 24 portfolio exits. Their latest portfolio exit was Petmate on September 15, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/15/2021

Acq - Fin - III

1

11/30/2020

Acquired

$99M

5

10/18/2019

Acquired

1

6/5/2019

Acq - Fin - II

Subscribe to see more

Subscribe to see more

10

6/19/2018

Acq - Fin - III

Subscribe to see more

Subscribe to see more

10

Date

9/15/2021

11/30/2020

10/18/2019

6/5/2019

6/19/2018

Exit

Acq - Fin - III

Acquired

Acquired

Acq - Fin - II

Acq - Fin - III

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

1

5

1

10

10

Olympus Partners Acquisitions

38 Acquisitions

Olympus Partners acquired 38 companies. Their latest acquisition was Excel Fitness Holdings on April 29, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

4/29/2022

$99M

Acq - Fin - II

2

3/31/2022

$99M

Acq - Fin - II

1

12/29/2020

Debt

$99M

$3.5M

Acq - Fin

2

1/6/2020

Subscribe to see more

$99M

Subscribe to see more

10

11/6/2019

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/29/2022

3/31/2022

12/29/2020

1/6/2020

11/6/2019

Investment Stage

Debt

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$3.5M

Note

Acq - Fin - II

Acq - Fin - II

Acq - Fin

Subscribe to see more

Subscribe to see more

Sources

2

1

2

10

10

Olympus Partners Fund History

8 Fund Histories

Olympus Partners has 8 funds, including Olympus Growth Fund VII.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/17/2017

Olympus Growth Fund VII

Buyouts & Acquisitions

Closed

$3,040M

2

6/30/2013

Olympus Growth Fund VI LP

Subscribe to see more

Subscribe to see more

$99M

10

3/15/2008

Olympus Debt Fund

Subscribe to see more

Subscribe to see more

$99M

10

5/1/2003

Olympus Growth Fund IV LP

Subscribe to see more

Subscribe to see more

$99M

10

4/23/1998

Olympus Growth Fund III LP

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

12/17/2017

6/30/2013

3/15/2008

5/1/2003

4/23/1998

Fund

Olympus Growth Fund VII

Olympus Growth Fund VI LP

Olympus Debt Fund

Olympus Growth Fund IV LP

Olympus Growth Fund III LP

Fund Type

Buyouts & Acquisitions

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Closed

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$3,040M

$99M

$99M

$99M

$99M

Sources

2

10

10

10

10

Olympus Partners Partners & Customers

2 Partners and customers

Olympus Partners has 2 strategic partners and customers. Olympus Partners recently partnered with Imbio on February 2, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

2/17/2021

Supplier

United States

Olympus Partners with Imbio to Bring AI-based Patient Selection Tools to Customers with SeleCT™ QCT Analysis Service. AI-based Software Providing Physicians with Quantitative Evaluation of CT Scans (QCT) for the Non-invasive Determination of Patient Eligibility for the Spiration Valve System Procedure to Treat Severe Emphysema.

CENTER VALLEY , Pa. , -LRB- February 17 , 2021 -RRB- -- Today , Olympus Partners announced a partnership with Imbio , LLC to provide physicians with the SeleCT ™ QCT analysis service to evaluate patient eligibility for treatment with the Spiration ® Valve System , an FDA-designated breakthrough device to treat severe emphysema , a form of chronic obstructive pulmonary disease -LRB- COPD -RRB- .

1

6/1/2019

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

2/17/2021

6/1/2019

Type

Supplier

Partner

Business Partner

Country

United States

United States

News Snippet

Olympus Partners with Imbio to Bring AI-based Patient Selection Tools to Customers with SeleCT™ QCT Analysis Service. AI-based Software Providing Physicians with Quantitative Evaluation of CT Scans (QCT) for the Non-invasive Determination of Patient Eligibility for the Spiration Valve System Procedure to Treat Severe Emphysema.

CENTER VALLEY , Pa. , -LRB- February 17 , 2021 -RRB- -- Today , Olympus Partners announced a partnership with Imbio , LLC to provide physicians with the SeleCT ™ QCT analysis service to evaluate patient eligibility for treatment with the Spiration ® Valve System , an FDA-designated breakthrough device to treat severe emphysema , a form of chronic obstructive pulmonary disease -LRB- COPD -RRB- .

Subscribe to see more

Subscribe to see more

Sources

1

10

Olympus Partners Service Providers

1 Service Provider

Olympus Partners has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Kirkland & Ellis

Acq - Fin

Counsel

General Counsel

Service Provider

Kirkland & Ellis

Associated Rounds

Acq - Fin

Provider Type

Counsel

Service Type

General Counsel

Partnership data by VentureSource

Olympus Partners Team

2 Team Members

Olympus Partners has 2 team members, including current Managing Partner, James A Conroy.

Name

Work History

Title

Status

James A Conroy

Managing Partner

Current

Robert S Morris

Managing Partner

Current

Name

James A Conroy

Robert S Morris

Work History

Title

Managing Partner

Managing Partner

Status

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.